“scaling up best practices in jordan” low cost, underutilized technologies to reduce maternal...
Post on 12-Jan-2016
219 Views
Preview:
TRANSCRIPT
“Scaling Up Best Practices in Jordan”
Low Cost, Underutilized Technologies to Reduce
Maternal Mortality in JordanBy
Sabry Hamza MD, Dr Ob/GynSabry Hamza MD, Dr Ob/GynChief of Party
Health System Strengthening ProjectAmman - Jordan
2
Highlights on Jordan
3
Highlights on Jordan “DHS 2007” Total Area (sq. km) 89,287
Total Population 5.7 million Total Fertility Rate 3.6 Less Than 15 Years
Old 37.3%
CPR (Modern) 57% (42%) MMR 41/100,000 live births
IMR 19 per 1000 live births
Illiteracy Rate (=>15) 9% Life Expectation (M,
F) 71.7 (70.8, 72.5)
4
Selected Best Practice Use Magnesium Sulfate for all patients
with pregnancy induced hypertension in all public hospitals in Jordan.
Magnesium Sulfate is the anticonvulsant of choice for treating eclampsia; more effective than diazepam, phenytoin, or lytic cocktail. Although it is a low cost effective treatment, Magnesium Sulfate was not available in MOH hospitals in Jordan.
5
Global Burden of Pre-eclampsia / Eclampsia
Recent estimates developed by
WHO indicate that the incidence of pre-eclampsia is estimated at 3.2% of live births, giving a total number of over 4 million cases each year, of which over 72,000 were fatal.
6
Problem in Jordan
The Jordanian National Maternal Mortality Study 1995/1996 highlighted that “hypertensive disorders with pregnancy” is the first most common direct obstetric cause of maternal mortality representing 27.8% of direct obstetric deaths and 20% of all maternal deaths.
7
Gaps
Magnesium Sulfate was not available in MOH hospitals.
Service providers were not trained on the use of Magnesium Sulfate.
Scaling up its use for eclampsia and severe
pre-eclampsia will contribute to reduction of
related maternal deaths.
8
Interventions to Address Gaps Interventions to Address Lack of MgSO4:Interventions to Address Lack of MgSO4:
Correct immediate shortage:Correct immediate shortage: Advocated to the Minister of Health. Emergency purchase procedure adopted.
Economies of scale through purchasing Economies of scale through purchasing needed quantities for 5 years:needed quantities for 5 years: Established a committee to project the
need. Developed feasible alternatives to
current purchasing process.
Interventions to Address Capacity Interventions to Address Capacity Building:Building:
9
Interventions to Address Gaps (cont.)
Evidence Based Clinical Guidelines Developed:Evidence Based Clinical Guidelines Developed:
10
Competency Based Training for Service Providers(Classroom & OJT):
Interventions to Address Gaps (cont.)
11
Clinical Performance Monitoring Checklist for Pre-eclampsia / Eclampsia:
Interventions to Address Gaps (cont.)
12
Progress to Date
13
Lessons Learned Didactic training alone does not
change providers’ attitudes and behaviors. Most providers adopt clinical protocols and master skills after on-the-job training with expert.
Application:Application: Continue to use the CBT methodology with a special focus on OJT through a highly qualified and extensively experienced team of local trainers.
14
Lessons Learned (cont.)
Training of service providers following the classic teaching approach sometimes faces challenges and resistance from their side to apply what they have learned.
Application:Application: Build the capacity of service providers to review the literature and look for the valid reliable technical knowledge and integrate that knowledge into their clinical practice through adopting evidence based medicine.
15
Lessons Learned (cont.) Establishing safe motherhood
committees at MOH hospitals proved effective to ensure availability of Magnesium Sulfate and oversee its utilization, but lacks sustainability and central level support.
Application:Application: link the committees with the quality directorate at central MOH and advocate for the formulation of a central safe motherhood committee to provide necessary formal support and institutionalize the use of Magnesium Sulfate nationwide.
16
Conclusion
“Women are not dying because of untreatable diseases. They are
dying because societies have yet to make the decision that their
lives are worth saving”.
Prof. Mahmoud Fathalla – from Egypt
FIGO Past President
17
New 7 Wonders of the World
Chichenitza, Mexico Colosseum, Italy
Taj Mahal, India Great Wall of China
Christ Redeemer, Brazil Machu Picchu, Peru Petra, Jordan
18
Thank You
top related